Inhalac 251
Dry powder inhalants are often used in the pulmonary route of administration. Its advantages include excellent ease of use, small size for portability, and no precise fit (relative to aerosol) between device excitation and patient breathing. In addition, because it does not contain Freon, it is more environmentally friendly. In use and storage, solid dosage forms have better physicochemical stability. Dry powder inhalants generally consist of a device, drugs and auxiliaries. Additives are added to ensure a smooth production process. Therefore, the particle properties of powders related to the process are important factors that need to be paid attention to in the design of prescriptions.
InhaLac® 251 is the finest sieved lactose, with a median particle size of approximately 50 microns. It is characterized by containing fine powder particles (more than ten percent of particles smaller than 15 microns), and a broad particle size distribution (peak width to height ratio 1.6)
previous item: Inhalac 230
next item: Inhalac 500





关闭返回